Health Care Industry
Industry: Email Alert RSS FeedHealth Canada reinstates Adderall XR.(Drug overview)
Clinical Psychiatry News, October, 2005 by Splete, Heidi
Patients in Canada with attention-deficit hyperactivity disorder are now able to obtain Adderall XR.
Sales of the controlled-release amphetamine mixed with salts, distributed by Shire Pharmaceuticals Group PLC, had been suspended earlier this year in Canada after the release of postmarketing reports of sudden death in 12 children in the United States who had taken the drug between 1999 and 2003.
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
At Shire's request, Health Canada, that country's drug regulatory agency, convened the New Drug Committee, a three-member panel of experts in pediatric cardiology, pediatric ...
Read the rest of this article with a Free Trial at HighBeam Research.